FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Monday

 

MS Lesions Quickly Detected with New MRI Technique




























Researchers developed a new way of using MRI (magnetic resonance imaging) to better distinguish multiple sclerosis (MS)-related “white spots” from similar brain lesions that corresponding to other conditions. Their article, “Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions,” was published in the Multiple Sclerosis Journal.

MRI is a valuable diagnostic tool for detecting brain abnormalities, being particularly sensitive in the evaluation of white matter lesions. These lesions are mostly the result of cerebral microangiopathy, a condition that affects the small vessels in the brain. However, demyelination (myelin destruction), a hallmark of MS, can also cause white matter lesions, but conventional MRI cannot always distinguish similar-looking lesions.

Researchers at The University of Nottingham and Nottingham University Hospitals NHS Trust tested if a special type of MRI, called a 3-T T2*-weighted MRI, could distinguish MS lesions from microangiopathic white matter brain lesions. This type of MRI is able to reveal white matter lesions that are centered on a vein, a distinctive feature of MS. The researchers studied its use in a total of 40 patients.

In the first part of the study, 10 patients with MS and 10 patients with microangiopathic white matter lesions underwent 3-T T2*-weighted brain MRI, and diagnostic rules were established according to the evaluation of scans. For validation purposes, 20 more patients, 13 with MS and 7 with microangiopathic lesions, were assessed with the same process by a blinded observer.

The results showed that all 10 MS patients in the first cohort had central veins visible in more than 45 percent of their brain lesions, while the 10 with non-MS lesions had central veins visible in less than 45 percent of lesions. When these diagnostic rules were applied to the second, blinded-observer cohort, the patients were correctly and quickly diagnosed, leading researchers to believe that this MRI procedure can have clinical application for the distinction of MS and microangiopathic lesions.

“We already knew that large research MRI scanners could detect the proportion of lesions with a vein in the brain’s white matter, but these scanners are not clinically available. So we wanted to find out whether a single brain scan in an NHS hospital scanner could also be effective in distinguishing between patients known to have MS and patients known to have non-MS brain lesions,” the study’s lead author, Dr. Nikos Evangelou, said in a press release. “We are excited to reveal that our results show that clinical application of this technique could supplement existing diagnostic methods for MS.”

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News